primary endpoint - Robuta Search

https://www.fiercebiotech.com/biotech/sage-tweaks-primary-endpoint-for-zuranolone-depression-trial-leaving-key-durability Sage tweaks primary endpoint for zuranolone depression trial, leaving key durability question... Nov 2, 2021 - Sage Therapeutics has slightly tweaked the primary endpoint for a phase 3 trial of the Biogen-partnered depression drug zuranolone, a move analysts say is... primary endpoint https://www.fda.gov/about-fda/division-patient-centered-development/clinician-reported-outcomes-co-primary-endpoint-stroke-treatment-device Clinician-Reported Outcomes in Co-Primary Endpoint for Stroke Treatment Device | FDA Use of UW-mRS along with a more traditional ClinRO can be used to validate this new ClinRO as it is used in clinical studies of acute ischemic stroke therapies. in co primary endpoint https://www.fiercebiotech.com/biotech/leo-tames-eczema-phase-2b-reporting-primary-endpoint-hit-ex-argenx-asset Leo's eczema prospect hits primary endpoint in phase 2b May 9, 2025 - Leo shared phase 2b data on temtokibart, reporting that the top three doses of the IL-22RA1 blocker beat placebo on the primary endpoint. leo s primary endpoint eczema prospect hits https://www.takeda.com/newsroom/newsreleases/2019/investigational-subcutaneous-formulation-of-vedolizumab-meets-primary-endpoint-in-achieving-clinical-remission-at-week-52-in-patients-with-moderately-to-severely-active-crohns-disease/ Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving... Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to... primary endpoint subcutaneous formulation vedolizumab meets https://www.gsk.com/en-gb/media/press-releases/pivotal-phase-iii-study-of-gsk-shingles-candidate-vaccine-meets-its-primary-endpoint/ Pivotal phase III study of GSK shingles candidate vaccine meets its primary endpoint | GSK GSK announced a phase III study to assess the efficacy of HZ/su, investigational vaccine for shingles, has met its primary endpoint. phase iii study https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/spago-nanomedicals-phase-i%2Fiia-study-tumorad-01-meets-a-primary-endpo-1164159 Spago Nanomedical's Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further... LUND, SE / ACCESS Newswire / May 6, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the independent Data... https://www.prnewswire.com/news-releases/taihos-tas-102-meets-primary-endpoint-of-improving-overall-survival-in-phase-iii-terra-study-in-asian-patients-with-refractory-metastatic-colorectal-cancer-300244624.html Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in... /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. of Tokyo announced on April 1 results from its Phase III TERRA study on its oral combination anticancer drug... https://www.gsk.com/en-gb/media/press-releases/primary-endpoint-met-in-comet-tail-phase-iii-trial-evaluating-intramuscular-administration-of-sotrovimab-for-early-treatment-of-covid-19/ Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of... Phase III IM administration data for sotrovimab. phase iii trial https://www.businesswire.com/news/home/20260427483039/en/Mirum-Pharmaceuticals-Announces-Primary-Endpoint-Met-in-Phase-2b-Portion-of-the-AZURE-1-Study-of-Brelovitug-in-Chronic-Hepatitis-Delta-Virus Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of... Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus https://www.merck.com/news/merck-announces-phase-3-keynote-355-trial-met-primary-endpoint-of-overall-survival-os-in-patients-with-metastatic-triple-negative-breast-cancer-whose-tumors-expressed-pd-l1-cps-%E2%89%A510/ Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients... Apr 17, 2026 - KEYTRUDA Is the First Anti-PD-1 Therapy in Combination With Chemotherapy to Show Statistically Significant OS for This Patient Population Merck (NYSE: MRK),... https://finviz.com/news/339449/karyopharms-phase-3-sentry-trial-in-myelofibrosis-met-first-co-primary-endpoint-demonstrating-statistically-significant-improvement-in-spleen-volume-reduction Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating... Stock screener for investors and traders, financial visualizations. https://www.merck.com/news/merck-and-pfizer-announce-that-investigational-sglt-2-inhibitor-ertugliflozin-met-primary-endpoint-in-two-phase-3-studies/ Merck and Pfizer Announce That Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint... May 11, 2026 - Ertugliflozin as Add-on to Metformin or in Initial Co-administration with Sitagliptin Showed Significant A1C Reductions in Adults with Type 2 Diabetes... sglt 2 inhibitor https://www.novartis.com/news/media-releases/novartis-investigational-novel-stamp-inhibitor-asciminib-abl001-meets-primary-endpoint-phase-iii-chronic-myeloid-leukemia-study Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase... https://www.aacr.org/about-the-aacr/newsroom/news-releases/phase-iii-katherine-clinical-trial-crossed-early-reporting-boundary-and-met-its-primary-endpoint/ Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint |... Dec 3, 2019 - Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint https://www.acc.org/about-acc/press-releases/2018/03/10/10/51/mon-8am-trial-for-gout-drug-meets-primary-endpoint-raises-safety-concerns Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns - American College of Cardiology